Distinguishing Urothelial Carcinoma in the Upper Urinary Tract from Benign Diseases with Hematuria Using FISH

被引:9
作者
Wang, Jiandong [1 ]
Wu, Jinrong [1 ]
Peng, Libo [1 ]
Tu, Pin [1 ]
Li, Wanchun [1 ]
Liu, Leilei [1 ]
Cheng, Wen [2 ]
Wang, Xuan [1 ]
Zhou, Shuigen [2 ]
Shi, Shanshan [1 ]
Ma, Henghui [1 ]
Lu, Guangming [3 ]
Zhou, Xiaojun [1 ]
机构
[1] Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Dept Pathol, Nanjing 210002, Jiangsu, Peoples R China
[2] Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Dept Urol, Nanjing 210002, Jiangsu, Peoples R China
[3] Nanjing Univ, Sch Med, Nanjing Jinling Hosp, Dept Radiol, Nanjing 210002, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Fluorescence in situ hybridization; Hematuria; Upper urinary tract; Urothelial carcinoma; IN-SITU HYBRIDIZATION; BLADDER-CANCER; DIAGNOSIS; CYTOLOGY; SURVEILLANCE; MULTITARGET; UTILITY; CELLS;
D O I
10.1159/000341622
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: The aims of this study were to evaluate the clinical utility of a fluorescence in situ hybridization (FISH) assay as a non-invasive molecular test to distinguish urothelial carcinoma (UC) in the upper urinary tract (UUT) from benign lesions presenting with hematuria. Study Design: The chromosomal abnormalities of chromosomes 3, 7, 17 and 9 (p16) in hematuria specimens from 34 patients with UUT-UC and 33 patients with benign disorders were detected using a set of fluorescently labeled DNA probes. The abnormalities of the chromosomes were determined and analyzed between UUT-UC and benign disorders. Results: Chromosomal abnormalities were detected in 25 of 34 (73.5%) patients with UUT-UC and in 2 of 33 (6.1%) patients with benign disorders (p < 0.001). Conclusions: FISH of chromosomes 3, 7, 9 and 17 performed on exfoliated cells from voided urine specimens may serve as a non-invasive tool to distinguish UUT-UC from benign disorders presenting with hematuria. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:533 / 538
页数:6
相关论文
共 26 条
[1]  
BIAN YL, 1995, ACTA CYTOL, V39, P733
[2]  
Bubendorf L, 2012, ACTA CYTOL, V55, P113
[3]   Fluorescence in situ hybridization in the diagnosis of urothelial carcinoma [J].
Bubendorf, Lukas .
ANNALES DE PATHOLOGIE, 2010, 30 :S117-S118
[4]   Fluorescence In Situ Hybridization for Detecting Urothelial Carcinoma A Clinicopathologic Study [J].
Caraway, Nancy P. ;
Khanna, Abha ;
Fernandez, Ricardo L. ;
Payne, Linda ;
Bassett, Roland L., Jr. ;
Zhang, Hua-Zhong ;
Kamat, Ashish ;
Katz, Ruth L. .
CANCER CYTOPATHOLOGY, 2010, 118 (05) :259-268
[5]   Computed Tomography-Urography for Upper Urinary Tract Imaging: Is It Required for All Patients Who Present with Hematuria? [J].
Cauberg, Evelyne C. C. ;
Nio, C. Y. ;
de la Rosette, Jean M. C. H. ;
Laguna, M. Pilar ;
de Reijke, Theo M. .
JOURNAL OF ENDOUROLOGY, 2011, 25 (11) :1733-1740
[6]   Performance of computed tomographic urography in diagnosis of upper urinary tract urothelial carcinoma, in patients presenting with hematuria: Systematic review and meta-analysis [J].
Chlapoutakis, Konstantinos ;
Theocharopoulos, Nicholas ;
Yarmenitis, Spyros ;
Damilakis, John .
EUROPEAN JOURNAL OF RADIOLOGY, 2010, 73 (02) :334-338
[7]   CT urography for hematuria [J].
Cowan, Nigel C. .
NATURE REVIEWS UROLOGY, 2012, 9 (04) :218-226
[8]   Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder [J].
Degtyar, P ;
Neulander, E ;
Zirkin, H ;
Yusim, I ;
Douvdevani, A ;
Mermershtain, W ;
Kaneti, J ;
Manor, E .
UROLOGY, 2004, 63 (02) :398-401
[9]   A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma [J].
Halling, KC ;
King, W ;
Sokolova, IA ;
Meyer, RG ;
Burkhardt, HM ;
Halling, AC ;
Cheville, JC ;
Sebo, TJ ;
Ramakumar, S ;
Stewart, CS ;
Pankratz, S ;
O'Kane, DJ ;
Seelig, SA ;
Lieber, MM ;
Jenkins, RB .
JOURNAL OF UROLOGY, 2000, 164 (05) :1768-1775
[10]   Bladder cancer detection using FISH (UroVysion assay) [J].
Halling, Kevin C. ;
Kipp, Benjamin R. .
ADVANCES IN ANATOMIC PATHOLOGY, 2008, 15 (05) :279-286